Campylobacter infection

Blaser MJ. Infections due to Campylobacter and related species. In: Fauci AS, Braunwald E, Kasper DL, et al. Harrison's principles of internal medicine. 17th ed. New York, NY: McGraw Hill; 2008:965-7.

Blaser MJ. Epidemiologic and clinical features of Campylobacter jejuni infections. J Infect Dis. 1997 Dec;176(suppl 2):S103-5.Full text  Abstract

World Health Organization. Campylobacter fact sheet. 1 May 2020 [internet publication].Full text

Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80.Full text  Abstract

Skirrow MB, Blaser MJ. Campylobacter jejuni. In: Infections of the gastrointestinal tract. 2nd ed. Blaser MJ, Smith PD, Ravdin JI, et al., eds. Philadelphia, PA: Lippincott Williams and Wilkins; 2002:719.

Riddle MS, DuPont HL, Connor BA. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. 2016 May;111(5):602-22.Full text  Abstract

World Gastroenterology Organisation (WGO). WGO practice guideline: acute diarrhea. 2012 [internet publication].Full text

1. Blaser MJ. Infections due to Campylobacter and related species. In: Fauci AS, Braunwald E, Kasper DL, et al. Harrison's principles of internal medicine. 17th ed. New York, NY: McGraw Hill; 2008:965-7.

2. Kaakoush NO, Castaño-Rodríguez N, Michell HM, Man SM. Global epidemiology of Campylobacter infection. Clin Microbiol Rev. 2015 Jul;28(3):687-720.Full text  Abstract

3. Centers for Disease Control and Prevention. Food safety: campylobacter. 14 April 2021 [internet publication].Full text

4. Blaser MJ. Epidemiologic and clinical features of Campylobacter jejuni infections. J Infect Dis. 1997 Dec;176(suppl 2):S103-5.Full text  Abstract

5. Fernández-Cruz A, Muñoz P, Mohedano R, et al. Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine (Baltimore). 2010 Sep;89(5):319-30. Abstract

6. World Health Organization. Campylobacter fact sheet. 1 May 2020 [internet publication].Full text

7. Tack DM, Ray L, Griffin PM, et al. Preliminary incidence and trends of infections with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 US sites, 2016-2019. MMWR Morb Mortal Wkly Rep. 2020 May 1;69(17):509-14.Full text  Abstract

8. Public Health England (UK). Research and analysis: Campylobacter data 2008 to 2017. 17 January 2017 [internet publication].Full text

9. Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 states, 2009. MMWR Morb Mortal Wkly Rep. 2010 Apr 16;59(14):418-22.Full text  Abstract

10. Skirrow MB. A demographic survey of campylobacter, salmonella, shigella infections in England: a public health laboratory service survey. Epidemiol Infect. 1987 Dec;99(3):647-57. Abstract

11. Green MS, Schwartz N, Peer V. Sex differences in campylobacteriosis incidence rates at different ages - a seven country, multi-year, meta-analysis. A potential mechanism for the infection. BMC Infect Dis. 2020 Aug 25;20(1):625.Full text  Abstract

12. Kovats RS, Edwards SJ, Charron D, et al. Climate variability and campylobacter infection: an international study. Int J Biometeorol. 2005 Mar;49(4):207-14. Abstract

13. de la Cabada Bauche J, Dupont HL. New developments in traveler's diarrhea. Gastroenterol Hepatol (NY). 2011 Feb;7(2):88-95.Full text  Abstract

14. Humphrey T, O’Brien S, Madsen M. Campylobacters as zoonotic pathogens: a food production perspective. Int J Food Microbiol. 2007 Jul 15;117(3):237-57. Abstract

15. Domingues AR, Pires SM, Halasa T, et al. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections. Epidemiol Infect. 2012 Jun;140(6):970-81.Full text  Abstract

16. Centers for Disease Control and Prevention. Travelers’ health. Laughlin ME, Chatham-Stephens K, Geissler AL. Chapter 4. Travel - related infectious diseases. 24 June 2019 [internet publication].Full text

17. van Putten JP, van Alphen LB, Wösten MM, et al. Molecular mechanisms of campylobacter infection. Curr Top Microbiol Immunol. 2009;337:197-229. Abstract

18. Haddad N, Marce C, Magras C, et al. An overview of methods used to clarify pathogenesis mechanisms of Campylobacter jejuni. J Food Prot. 2010 Apr;73(4):786-802.Full text  Abstract

19. Dasti JI, Tareen AM, Lugert R, et al. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol. 2010 Apr;300(4):205-11. Abstract

20. Kapperud G, Lassen J, Ostroff SM, et al. Clinical features of sporadic Campylobacter infections in Norway. Scand J Infect Dis. 1992;24(6):741-9. Abstract

21. Saeed AM, Harris NV, DiGiacomo RF. The role of exposure to animals in the etiology of Campylobacter jejuni/coli enteritis. Am J Epidemiol. 1993 Jan 1;137(1):108-14. Abstract

22. Doorduyn Y, Van Den Brandhof WE, Van Duynhoven YT, et al. Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in The Netherlands: a case-control study. Epidemiol Infect. 2010 Oct;138(10):1391-404. Abstract

23. Sorvillo FJ, Lieb LE, Waterman SH. Incidence of campylobacteriosis among patients with AIDS in Los Angeles County. J Acquir Immune Defic Syndr. 1991;4(6):598-602. Abstract

24. Guzman-Herrador B, Carlander A, Etelberg S, et al. Waterborne outbreaks in the Nordic countries, 1998 to 2012. Euro Surveill. 2015 Jun 18;20(24):21160.Full text  Abstract

25. Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80.Full text  Abstract

26. Tam CC, Higgins CD, Neal KR, et al; Campylobacter Case-Control Study Group. Chicken consumption and use of acid-suppressing medications as risk factors for Campylobacter enteritis, England. Emerg Infect Dis. 2009 Sep;15(9):1402-8.Full text  Abstract

27. Ejemot-Nwadiaro RI, Ehiri JE, Arikpo D, et al. Hand-washing promotion for preventing diarrhoea. Cochrane Database Syst Rev. 2021 Jan 6;12(1):CD004265.Full text  Abstract

28. Havelaar AH, van Pelt W, Ang CW et al. Immunity to Campylobacter: its role in risk assessment and epidemiology. Crit Rev Microbiol. 2009;35(1):1-22. Abstract

29. Skirrow MB, Blaser MJ. Campylobacter jejuni. In: Infections of the gastrointestinal tract. 2nd ed. Blaser MJ, Smith PD, Ravdin JI, et al., eds. Philadelphia, PA: Lippincott Williams and Wilkins; 2002:719.

30. White AE, Ciampa N, Chen Y, et al. Characteristics of Campylobacter and salmonella infections and acute gastroenteritis in older adults in Australia, Canada, and the United States. Clin Infect Dis. 2019 Oct 15;69(9):1545-52.Full text  Abstract

31. Crim SM, Iwamoto M, Huang JY, et al. Incidence and trends of infection with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 US sites, 2006-2013. MMWR Morb Mortal Wkly Rep. 2014 Apr 18;63(15):328-32.Full text  Abstract

32. Abubakar I, Irvine L, Aldus CF, et al. A systematic review of the clinical, public health and cost-effectiveness of rapid diagnostic tests for the detection and identification of bacterial intestinal pathogens in faeces and food. Health Technol Assess. 2007 Sep;11(36):1-216.Full text  Abstract

33. van Duin JM, Banffer JR, Nuyten PJ, et al. Comparison of Western blot, counterimmunoelectrophoresis, complement fixation, and enzyme-linked immunosorbent assay for the diagnosis of Campylobacter infection. Serodiag Immunother Infect Dis. 1993 Dec;5(4):231.

34. Riddle MS, DuPont HL, Connor BA. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. 2016 May;111(5):602-22.Full text  Abstract

35. Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev. 2016 Dec 13;12(12):CD006519.Full text  Abstract

36. Ternhag A, Asikainen T, Giesecke J, et al. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis. 2007 Mar 1;44(5):696-700. Abstract

37. World Gastroenterology Organisation (WGO). WGO practice guideline: acute diarrhea. 2012 [internet publication].Full text

38. Centers for Disease Control and Prevention. Antibiotic/antimicrobial resistance (AR/AMR). 23 Novemvber 2021 [internet publication].Full text

39. US Food and Drug Administration. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. July 2016 [internet publication].Full text

40. US Food and Drug Administration. FDA Drug Safety Communication. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. October 2018 [internet publication].Full text

41. US Food and Drug Administration. FDA Drug Safety Communication. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. December 2018 [internet publication].Full text

42. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. 19 March 2019 [internet publication].Full text

43. Collinson S, Deans A, Padua-Zamora A, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2020 Dec 8;12(12):CD003048.Full text  Abstract

44. Pérez-Gaxiola G, Cuello-García CA, Florez ID, Pérez-Pico VM. Smectite for acute infectious diarrhoea in children. Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011526.Full text  Abstract

45. Hlashwayo DF, Barbosa F, Langa S, et al. A systematic review of in vitro activity of medicinal plants from sub-Saharan Africa against Campylobacter spp. Evid Based Complement Alternat Med. 2020 May 15;2020:9485364.Full text  Abstract

46. Ruiz-Palacios GM. The health burden of Campylobacter infection and impact of antimicrobial resistance: playing chicken. Clin Infect Dis. 2007 Mar 1;44(5):701-3. Abstract

47. Monno R, Rendina M, Ceci G, et al. Campylobacter fetus bacteremia in an immunocompromised patient: case report and review of literature. New Microbiol. 2004 Jul;27(3):281-5. Abstract

48. Uzoigwe C. Campylobacter infections of the pericardium and myocardium. Clin Microbiol Infect. 2005 Apr;11(4):253-5.Full text  Abstract

49. Peterson MC. Rheumatic manifestations of Campylobacter jejuni and C. fetus infections in adults. Scand J Rheumatol. 1994;23(4):167-70. Abstract

50. Poropatich KO, Walker CL, Black RE. Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review. J Health Popul Nutr. 2010 Dec;28(6):545-52.Full text  Abstract